BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33031312)

  • 1. Diagnostic performance of blood-based liquid biopsies in hepatocellular carcinoma: A protocol for systematic review and meta-analysis.
    Zhang T; Yin M; Wang L; Cao W; Zhong S
    Medicine (Baltimore); 2020 Oct; 99(41):e22594. PubMed ID: 33031312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of circulating MicroRNAs in acute ischemic stroke: A protocol for systematic review and meta-analysis.
    Cao W; Zhang T; Wang L; Fu J; Jin H
    Medicine (Baltimore); 2020 Oct; 99(40):e22353. PubMed ID: 33019412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of contrast-enhanced ultrasound in predicting postoperative recurrence of hepatocellular carcinoma: A protocol for systematic review and meta-analysis.
    Fu J; Tang J; Luo H; Wu W
    Medicine (Baltimore); 2021 Jun; 100(22):e25984. PubMed ID: 34087841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of contrast-enhanced ultrasound for microvascular invasion of hepatocellular carcinoma: A protocol for systematic review and meta-analysis.
    Chen Y; Qiao H; Lian Z; Li C; Xiang Y
    Medicine (Baltimore); 2022 Apr; 101(15):e29083. PubMed ID: 35475795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.
    Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X
    Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis.
    Tao P; Gao L; Li H; Wang B; Li X; Zhang Y; Chen H
    Medicine (Baltimore); 2020 Dec; 99(52):e23841. PubMed ID: 33350772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis.
    Thevathasan T; Colbatzky T; Schmelzle M; Pratschke J; Krenzien F
    BMJ Open; 2021 Aug; 11(8):e045733. PubMed ID: 34376442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high-quality nursing care on psychological outcomes and quality of life in patients with hepatocellular carcinoma: A protocol of systematic review and meta-analysis.
    Zhang L; Zhang X; Cui Z; Zhou L; Qu K; Wang N
    Medicine (Baltimore); 2020 Aug; 99(35):e21855. PubMed ID: 32871909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Raman spectroscopy in the diagnosis of hepatocellular carcinoma: A protocol for systematic review and meta-analysis.
    Jin H; Zhang M; Jia K; Huang L
    Medicine (Baltimore); 2020 Dec; 99(52):e23884. PubMed ID: 33350784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis.
    Shi X; Li Q; Wang Y
    Medicine (Baltimore); 2021 Jan; 100(3):e23957. PubMed ID: 33545975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally Expressed Circular RNAs are Promising Biomarkers for Diagnosis of Hepatocellular Carcinoma: a Meta-Analysis.
    Yu G; Yang L; Zhou J; Zhang L; Xia L
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of arginase-1 expression in the diagnosis of liver cancer: A protocol for a systematic review.
    Wang X; Xu Y; Wang R; Dai N; Zhang W; Li F
    Medicine (Baltimore); 2020 Feb; 99(9):e19159. PubMed ID: 32118719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
    Chu X; Wang R; Song G; Jiang X
    Medicine (Baltimore); 2021 Apr; 100(13):e25356. PubMed ID: 33787637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsies for hepatocellular carcinoma.
    Su YH; Kim AK; Jain S
    Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
    J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver stiffness measured by magnetic resonance elastography in early recurrence of hepatocellular carcinoma after treatment: A protocol for systematic review and meta analysis.
    Zhao H; Zhang L; Chen H
    Medicine (Baltimore); 2021 Jun; 100(23):e26183. PubMed ID: 34115001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of artificial intelligence to detect genetic diseases with facial phenotypes: A protocol for systematic review and meta analysis.
    Qin B; Quan Q; Wu J; Liang L; Li D
    Medicine (Baltimore); 2020 Jul; 99(27):e20989. PubMed ID: 32629715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
    Hao QQ; Chen GY; Zhang JH; Sheng JH; Gao Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7496. PubMed ID: 28700498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of ibuprofen in acute mountain sickness: A protocol for systematic review and meta-analysis.
    Yi H; Wang K; Gan X; Li L; Zhang Q; Xiang J; Yuan X; Zhang Y; Wang Y
    Medicine (Baltimore); 2020 Nov; 99(46):e23233. PubMed ID: 33181710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.